“The pharmaceutical industry is very good at being reactive. If something happens, they have very clear processes, but they’re not so good anticipating change.”

David Schneider, Founder & CEO of Qualifyze, brings more than a decade of experience working in investment banking (JP Morgan), Fortune 500 companies (BASF), and management consulting (McKinsey). He now leads Qualifyze, a company transforming supply risk management in the pharmaceutical industry.

With operations across Frankfurt, Barcelona, and now Jersey City, Qualifyze serves around 1,400 pharmaceutical companies globally and has inspected over 4,000 production sites worldwide.

In the latest PharmaSource podcast, David and Qualifyze’s Chief Product Officer Martin Lehmann discuss how data-driven approaches can help pharmaceutical supply chains adapt to geopolitical pressures and uncertainty.

Meet the Qualifyze team at CDMO Live 2025

Read the full article